FDA approved new drug bulletin: torsemide (Demadex), trimetrexate glucuronate (neuTrexin).
D000328:Adult; D001942:Breast Feeding; D002648:Child; D004338:Drug Combinations; D004347:Drug Interactions; D005260:Female; D005965:Glucuronates / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010353:Patient Education as Topic; D011247:Pregnancy; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use*; D000077786:Torsemide; D016597:Trimetrexate / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D004338:Drug Combinations; D005965:Glucuronates; D013449:Sulfonamides; C056321:trimetrexate glucuronate; D016597:Trimetrexate; D000077786:Torsemide